NAS:ATAI (Germany)  
ATAI Life Sciences NV logo

ATAI Life Sciences NV

$ 4.70 +0.015 (+0.32%) 11:43 AM EST
P/E:
At Loss
P/B:
2.13
Market Cap:
$ 734.55M
Enterprise V:
$ 418.04M
Volume:
262.44K
Avg Vol (2M):
818.30K
Also Trade In:
Volume:
262.44K
Market Cap $:
734.55M
PE Ratio:
At Loss
Avg Vol (2-Month):
818.30K
Enterprise Value $:
418.04M
PB Ratio:
2.13
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

ATAI Life Sciences NV
c/o Mindspace, Krausenstrasse 9-10, Berlin, BB, DEU, 10117
Description
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
Name Current Vs Industry Vs History
Cash-To-Debt 461.95
Equity-to-Asset 0.9
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.12
Distress
Grey
Safe
Beneish M-Score -2.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.83
9-Day RSI 66.81
14-Day RSI 63.45
6-1 Month Momentum % -27.97
12-1 Month Momentum % -68.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.79
Quick Ratio 15.79
Cash Ratio 15.16

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-15 Est.)

ATAI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ATAI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.496
EPS (TTM) ($) -1.44
Beta 0
Volatility % 46.47
14-Day RSI 63.45
14-Day ATR ($) 0.289991
20-Day SMA ($) 4.145
12-1 Month Momentum % -68.8
52-Week Range ($) 2.95 - 17.9
Shares Outstanding (Mil) 160.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ATAI Life Sciences NV Filings

Document Form Filing Date
No Filing Data

Headlines

See More